Last reviewed · How we verify
Slow Titration
Slow Titration is a medication that helps to gradually increase the dose of a drug to minimize side effects.
Slow Titration is a medication that helps to gradually increase the dose of a drug to minimize side effects. Used for Atrial fibrillation for stroke prevention.
At a glance
| Generic name | Slow Titration |
|---|---|
| Sponsor | University of Florida |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
Mechanism of action
This is achieved by slowly increasing the dose over time, allowing the body to adjust to the medication. This approach can help to reduce the risk of adverse events and improve patient compliance.
Approved indications
- Atrial fibrillation for stroke prevention
Common side effects
- Headache
- Dizziness
- Nausea
Key clinical trials
- Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS) (PHASE1, PHASE2)
- Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2) (NA)
- Depressed Mood Improvement Through Nicotine Dosing 3 (PHASE2)
- Dopaminergic Dysfunction in Late-Life Depression (PHASE2)
- Efficacy and Safety of Pregabalin/Tizanidine vs. Pregabalin in Patients With Fibromyalgia (NA)
- A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight (PHASE2)
- A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes (PHASE2)
- A Study to Evaluate the Efficacy and Safety of CX11 Tablets in Overweight/Obese Participants (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Slow Titration CI brief — competitive landscape report
- Slow Titration updates RSS · CI watch RSS
- University of Florida portfolio CI